To define the influence of nonalcoholic fatty liver disease (NAFLD) and its associated comorbidities on liver transplant outcomes
The global prevalence of non-alcoholic fatty liver disease (NAFLD) is rising at an alarming rate, dr...
The rising tide of non-alcoholic fatty liver disease (NAFLD) associated with the obesity epidemic is...
The metabolic syndrome (MS), which includes obesity, dyslipidaemia, hypertension and hyperglycaemia ...
To define the influence of nonalcoholic fatty liver disease (NAFLD) and its associated comorbidities...
Nonalcoholic fatty liver disease (NAFLD) affects 25% of the global adult population with a range of ...
Non-alcoholic fatty liver disease (NAFLD), specifically its progressive form non-alcoholic steatohep...
Because of global epidemics of obesity and type 2 diabetes, the prevalence of non-alcoholic fatty li...
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in many c...
The rising tide of non-alcoholic fatty liver disease (NAFLD) associated with the obesity epidemic is...
Non-alcoholic fatty liver disease (NAFLD), specifically its progressive form non-alcoholic steatohep...
Nonalcoholic fatty liver disease (NAFLD) represents one of the most diffuse liver diseases worldwide...
Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) is a challenging and mult...
Background & Aims: Non-alcoholic fatty liver disease (NAFLD) is an emerging cause of graft dysfu...
© 2020 Authors. Nonalcoholic fatty liver disease (NAFLD) is a hepatic mani-festation of metabolic sy...
Liver transplant is the unique curative therapy for patients with acute liver failure or end-stage l...
The global prevalence of non-alcoholic fatty liver disease (NAFLD) is rising at an alarming rate, dr...
The rising tide of non-alcoholic fatty liver disease (NAFLD) associated with the obesity epidemic is...
The metabolic syndrome (MS), which includes obesity, dyslipidaemia, hypertension and hyperglycaemia ...
To define the influence of nonalcoholic fatty liver disease (NAFLD) and its associated comorbidities...
Nonalcoholic fatty liver disease (NAFLD) affects 25% of the global adult population with a range of ...
Non-alcoholic fatty liver disease (NAFLD), specifically its progressive form non-alcoholic steatohep...
Because of global epidemics of obesity and type 2 diabetes, the prevalence of non-alcoholic fatty li...
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in many c...
The rising tide of non-alcoholic fatty liver disease (NAFLD) associated with the obesity epidemic is...
Non-alcoholic fatty liver disease (NAFLD), specifically its progressive form non-alcoholic steatohep...
Nonalcoholic fatty liver disease (NAFLD) represents one of the most diffuse liver diseases worldwide...
Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) is a challenging and mult...
Background & Aims: Non-alcoholic fatty liver disease (NAFLD) is an emerging cause of graft dysfu...
© 2020 Authors. Nonalcoholic fatty liver disease (NAFLD) is a hepatic mani-festation of metabolic sy...
Liver transplant is the unique curative therapy for patients with acute liver failure or end-stage l...
The global prevalence of non-alcoholic fatty liver disease (NAFLD) is rising at an alarming rate, dr...
The rising tide of non-alcoholic fatty liver disease (NAFLD) associated with the obesity epidemic is...
The metabolic syndrome (MS), which includes obesity, dyslipidaemia, hypertension and hyperglycaemia ...
DOI
Add to ORKG